Funder: National Institutes of Health
Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (final closing date)
Funding Amounts: Up to $150,000 direct costs/year, max 2 years; estimated total program funding $700,000; ~3 awards expected.
Summary: Supports revision applications to active NCI U01 projects to incorporate and validate novel technologies developed via the NCI IMAT program to accelerate cancer research.
Key Information: Only currently funded NCI U01 projects eligible; technology must be IMAT-supported and not developed by the parent U01 PI.